Pay-To-Delay Ban Dropped From Healthcare Reform
8 CommentsBy Ed Silverman // March 18th, 2010 // 7:39 am
• Pharma Blog » Archives
Federal Trade Commission
FTC Wants More Staff To Tackle Biopharma Mergers
2 CommentsBy Ed Silverman // February 4th, 2010 // 8:18 am
FTC Presses For An End To ‘Pay-To-Delay’ Deals
16 CommentsBy Ed Silverman // January 13th, 2010 // 8:27 am
Abbott & Teva: Pay-To-Delay Or Legit Settlement?
1 CommentBy Ed Silverman // December 1st, 2009 // 7:50 am
Pharma Watchdog Nominated As An FTC Commish
2 CommentsBy Ed Silverman // November 19th, 2009 // 7:41 am
FTC Eyes Supply Dispute Between Drugmakers
2 CommentsBy Ed Silverman // November 13th, 2009 // 8:05 am
Senate Panel Vote: Limit Pay-To-Delay Generic Deals
2 CommentsBy Ed Silverman // October 15th, 2009 // 4:58 pm
FTC Holds Roundtable On Follow-On Biologics
4 CommentsBy Ed Silverman // November 21st, 2008 // 7:22 am